Recommendation ID
NG206/02
Question

A core outcome set: What core set of relevant health outcome measures should be used for trials of treatments for ME/CFS and managing symptoms of ME/CFS?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made this recommendation, see the rationale section on managing ME/CFS. Full details of the evidence and the committee's discussion are in evidence review G: nonpharmacological management of ME/CFS.


Source guidance details

Comes from guidance
Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management
Number
NG206
Date issued
October 2021

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/10/2021